MET and pancreatic neoplasm: Collectively, these findings demonstrate that c-Met CAR macrophages effectively inhibit Angiogenesis within the pancreatic cancer tumor microenvironment, promote normalization of tumor vasculature, and thereby effectively delay tumor progression.